Portfolio company
Peroxitech Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Peroxitech Therapeutics develops peptide-based treatments for acute lung injury and respiratory distress to serve patients with severe inflammatory conditions.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Peroxitech
This biopharmaceutical company develops peptide-based therapeutics to treat acute lung injury and other oxidative injury diseases for patients and healthcare providers.
Aqualung
Aqualung Therapeutics develops immunotherapeutic monoclonal antibodies for patients suffering from inflammatory lung injuries and life-threatening fibrosis.
AirNexis Therapeutics
This company develops inhaled small molecule medicines to treat chronic obstructive pulmonary disease for patients with respiratory conditions.
Kinaset Therapeutics
This biopharmaceutical company develops inhaled anti-inflammatory therapies to treat patients with severe asthma and other respiratory diseases.
Clarametyx Biosciences
This company develops immune-enabling therapies targeting bacterial biofilms for patients with chronic and progressive respiratory diseases.
Avalyn Pharma
The company develops inhaled medicines to treat patients with rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases.
Breath Therapeutics
This biopharmaceutical company develops inhaled drug-aerosol therapies for patients with bronchiolitis obliterans syndrome and other severe respiratory diseases.
Halo Therapeutics
This company develops small-molecule antiviral nasal sprays to treat respiratory viral infections for patients suffering from conditions like Covid-19.